Cisco
CSCO
NVIDIA
NVDA
Broadcom
AVGO
4
Taiwan Semiconductor
TSM
5
ASML Holding
ASML
US Stock MarketDetailed Quotes
INO Inovio Pharmaceuticals
- 1.7300
- -0.0300-1.70%
Close Mar 28 16:00 ET
- 1.7600
- +0.0300+1.73%
Post 19:56 ET
63.43MMarket Cap-0.44P/E (TTM)
1.7700High1.6800Low634.16KVolume1.7600Open1.7600Pre Close1.09MTurnover1.92%Turnover RatioLossP/E (Static)36.67MShares14.748052wk High0.93P/B57.27MFloat Cap1.680052wk Low--Dividend TTM33.10MShs Float2352.0000Historical High--Div YieldTTM5.11%Amplitude1.6800Historical Low1.7170Avg Price1Lot Size
Inovio Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 16.31%-104.08M | 25.16%-19.66M | 5.73%-27.44M | 12.70%-28.21M | 21.56%-28.76M | 42.48%-124.37M | 27.69%-26.28M | 56.85%-29.11M | 36.05%-32.31M | 40.75%-36.66M |
| Net income from continuing operations | 20.62%-107.25M | 22.48%-19.38M | 25.83%-25.17M | 9.28%-32.24M | 25.04%-30.47M | 51.71%-135.12M | 54.09%-25M | 10.20%-33.93M | 67.25%-35.53M | 48.59%-40.65M |
| Operating gains losses | -94.47%240.74K | -206.78%-1.2M | 242.40%262.15K | -71.87%357.61K | -61.87%817.19K | -51.68%4.35M | -70.55%1.12M | -114.73%-184.1K | 35.76%1.27M | -28.89%2.14M |
| Depreciation and amortization | -10.66%3.13M | 342.76%775.83K | -25.84%765.86K | -27.53%828.63K | -34.06%759.73K | -36.25%3.5M | -87.01%175.23K | -24.16%1.03M | -18.91%1.14M | -16.25%1.15M |
| Deferred tax | --0 | ---- | ---- | ---- | ---- | ---32.05K | ---- | ---- | ---- | ---- |
| Other non cash items | -328.26%-355.65K | --0 | --0 | --0 | -61.66%-355.65K | -16.67%155.81K | -9.94%282.33K | 0.00%-220K | 0.00%313.49K | 0.00%-220K |
| Change In working capital | 74.03%-2.66M | 65.37%-731.05K | 61.26%-2.86M | 179.17%1.78M | -157.61%-851.25K | -151.73%-10.26M | -116.35%-2.11M | 79.85%-7.38M | -105.19%-2.24M | 329.31%1.48M |
| -Change in receivables | -87.08%1.21M | 354.25%663.68K | -103.00%-89.07K | 1,058.35%777.42K | -102.18%-145.85K | 351.82%9.33M | 84.25%-261.03K | 130.24%2.97M | 97.91%-81.12K | 1,138.45%6.7M |
| -Change in prepaid assets | -96.20%1.48M | 359.45%686.41K | 139.27%748.74K | -199.01%-1.85M | -95.18%1.9M | 831.20%39.02M | -101.92%-264.56K | -22.57%-1.91M | 107.57%1.87M | 455.75%39.32M |
| -Change in payables and accrued expense | 93.16%-3.71M | -174.79%-1.5M | 62.00%-2.98M | 215.27%3.28M | 94.50%-2.5M | -264.92%-54.22M | -16.06%2.01M | 71.36%-7.85M | -104.35%-2.84M | -507.22%-45.54M |
| -Change in other current assets | -50.59%38.9K | --0 | -68.33%19.5K | 234.98%19.4K | --0 | -89.39%78.73K | --0 | -9.66%61.58K | -102.85%-14.37K | -79.26%31.53K |
| -Change in other current liabilities | 95.54%-109.41K | --0 | -127.58%-21.92K | --0 | -105.31%-87.49K | -19.71%-2.45M | -281.76%-3.72M | -88.14%79.46K | 81.16%-462.38K | 132.57%1.65M |
| -Change in other working capital | 22.15%-1.57M | -559.69%-580.15K | 27.83%-534.87K | 37.31%-446.59K | 98.30%-11.79K | 24.87%-2.02M | 118.73%126.2K | 92.36%-741.11K | -108.57%-712.38K | -9.31%-693.69K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 16.31%-104.08M | 25.16%-19.66M | 5.73%-27.44M | 12.70%-28.21M | 21.56%-28.76M | 42.48%-124.37M | 27.69%-26.28M | 56.85%-29.11M | 36.05%-32.31M | 40.75%-36.66M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 19.13%104.07M | 73.71%34.64M | 356.25%14.08M | -81.51%9.97M | 138.86%45.38M | -20.29%87.36M | -63.07%19.94M | -112.33%-5.49M | 623.16%53.91M | -10.93%19M |
| Net PPE purchase and sale | -107.26%-428.51K | -59.99%59.32K | --0 | -1,791.09%-452.25K | -100.62%-35.58K | 708.61%5.9M | 189.80%148.26K | --0 | 96.67%-23.92K | --5.77M |
| Net investment purchase and sale | 28.29%104.5M | 74.72%34.59M | 356.25%14.08M | -80.68%10.42M | 243.40%45.42M | -27.63%81.46M | -63.45%19.8M | -112.31%-5.49M | 662.55%53.93M | -43.32%13.23M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 19.13%104.07M | 73.71%34.64M | 356.25%14.08M | -81.51%9.97M | 138.86%45.38M | -20.29%87.36M | -63.07%19.94M | -112.33%-5.49M | 623.16%53.91M | -10.93%19M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 930.52%51.48M | 1,485.47%29.15M | -5.44%660.65K | 1,045.85%33.03M | -2,575.77%-11.36M | -93.90%5M | -72.43%1.84M | -81.67%698.63K | -93.29%2.88M | -101.49%-424.7K |
| Net issuance payments of debt | ---16.42M | --0 | --0 | --0 | ---16.42M | --0 | --0 | --0 | --0 | --0 |
| Net common stock issuance | 559.74%36.03M | 611.62%13.08M | -5.82%667.07K | 485.20%17.06M | --5.23M | -93.42%5.46M | -72.43%1.84M | -81.19%708.28K | -93.25%2.92M | --0 |
| Proceeds from stock option exercised by employees | --32.28M | --16.06M | --16.15M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | 9.83%-420.8K | --0 | -167,286.68%-16.15M | 49,357.61%15.91M | 58.97%-174.25K | 66.61%-466.65K | --0 | 79.85%-9.65K | 90.01%-32.29K | 58.62%-424.7K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 930.52%51.48M | 1,485.47%29.15M | -5.44%660.65K | 1,045.85%33.03M | -2,575.77%-11.36M | -93.90%5M | -72.43%1.84M | -81.67%698.63K | -93.29%2.88M | -101.49%-424.7K |
| Net cash flow | ||||||||||
| Beginning cash position | -69.11%14.31M | 15.33%21.69M | -34.75%34.39M | -30.58%19.6M | -69.11%14.31M | -34.88%46.33M | -14.48%18.8M | 28.25%52.71M | -52.15%28.24M | -34.88%46.33M |
| Current changes in cash | 260.77%51.47M | 1,081.83%44.13M | 62.53%-12.7M | -39.57%14.79M | 129.07%5.26M | -29.15%-32.01M | -118.47%-4.49M | -77.54%-33.91M | 236.79%24.47M | -49.16%-18.09M |
| Effect of exchange rate changes | 926.61%32.4K | --0 | --0 | --0 | 1,789.42%32.4K | 84.66%-3.92K | -96.09%483 | 87.27%-2.11K | 97.46%-376 | 70.74%-1.92K |
| End cash Position | 359.88%65.81M | 359.88%65.81M | 15.33%21.69M | -34.75%34.39M | -30.58%19.6M | -69.11%14.31M | -69.11%14.31M | -14.48%18.8M | 28.25%52.71M | -52.15%28.24M |
| Free cash flow | 16.14%-104.56M | 25.16%-19.66M | 5.73%-27.44M | 11.37%-28.66M | 22.09%-28.8M | 42.59%-124.69M | 28.02%-26.28M | 56.91%-29.11M | 36.89%-32.34M | 40.27%-36.96M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings